This statistic shows the revenue of biotechnology R&D in China from 2008 to 2012, with a projection until 2018. In 2010, revenues of biotechnology R&D in China amounted to approximately 210 million U.S. dollars.
Revenue of biotechnology R&D (SIC 72.11) in China from 2008 to 2018 (in million U.S. dollars)
Other statistics that may interest you Vaccine industry in China
Background
6
- Premium Statistic Birth rate in China 2000-2050
- Premium Statistic Infectious diseases in China 2021, by incidence rate
- Premium Statistic Infectious diseases in China 2021, by mortality rate
- Premium Statistic Influenza incidence rate in China 2015-2021
- Basic Statistic COVID-19 confirmed and death case development in China 2020-2022
- Premium Statistic Public interests over adult vaccines in China 2022, by type of vaccines
Market overview
6
- Basic Statistic Revenues of top vaccine manufacturing companies worldwide 2021
- Premium Statistic Vaccine market size in China 2016-2025
- Premium Statistic Vaccine release volume in China 2008-2021
- Premium Statistic Leading vaccine producers in China 2020, based on lot release contract price
- Basic Statistic Vaccination coverage in China 1990-2022, by vaccine
- Basic Statistic COVID-19 vaccination doses in China 2020-2022
Class I vaccines
6
- Premium Statistic Lot release volume of class I vaccines in China 2013-2020
- Premium Statistic Lot release volume of class I vaccines in China 2020, by type
- Premium Statistic Total lot release volume of DTP vaccinations in China 2015-2020
- Premium Statistic Market share of DTP vaccine manufacturers in China 2020
- Premium Statistic Total lot release volume of MMR vaccinations in China 2015-2020
- Premium Statistic Lot release volume distribution of major MMR vaccine manufacturers in China 2020
Class II vaccines
6
- Premium Statistic Market size of class II vaccines in China 2015-2020
- Premium Statistic Lot release volume of class II vaccines in China 2013-2020
- Premium Statistic Market share of major quadrivalent flu vaccine manufacturers in China 2022
- Premium Statistic Total lot release volume of HPV vaccines in China 2017-2022
- Premium Statistic HPV vaccine manufacturers' market share in China 2022
- Premium Statistic Number of COVID-19 vaccine doses produced in China 2021-2022
International trade
6
- Premium Statistic Import value of human vaccines in China 2017-2022
- Premium Statistic Import volume of human vaccines in China 2017-2022
- Premium Statistic Export value of human vaccines from China 2017-2022
- Premium Statistic Export volume of human vaccines from China 2017-2022
- Premium Statistic Number of Chinese COVID-19 vaccines sold overseas 2020-2022, by region
- Premium Statistic International deliveries of Chinese COVID-19 vaccines 2020-2022, by region
Further related statistics
9
- Hourly wages of dishwashers in the U.S. 2022-2023, by percentile distribution
- MorphoSys' research & development expenditure 2006-2023
- Merck & Co - expenditure on research and development 2006-2023
- AstraZeneca's expenditure on research and development 2006-2023
- Medicinal market growth worldwide including rebates 2009-2018
- Expenditure worldwide on diabetes by market 2013-2018
- Global ITO and BPO - Value of industrywide contracts 2012
- R&D expenditure in U.S. biotechnology 2009-2010 by type
- Information technology outsourcing market by function 2006-2011
Further Content: You might find this interesting as well
Statistics
- Hourly wages of dishwashers in the U.S. 2022-2023, by percentile distribution
- MorphoSys' research & development expenditure 2006-2023
- Merck & Co - expenditure on research and development 2006-2023
- AstraZeneca's expenditure on research and development 2006-2023
- Medicinal market growth worldwide including rebates 2009-2018
- Expenditure worldwide on diabetes by market 2013-2018
- Global ITO and BPO - Value of industrywide contracts 2012
- R&D expenditure in U.S. biotechnology 2009-2010 by type
- Information technology outsourcing market by function 2006-2011
Statista. (October 14, 2014). Revenue of biotechnology R&D (SIC 72.11) in China from 2008 to 2018 (in million U.S. dollars) [Graph]. In Statista. Retrieved November 09, 2024, from https://www.statista.com/forecasts/332392/china-biotechnology-randd-revenue-forecast-sic-7211
Statista. "Revenue of biotechnology R&D (SIC 72.11) in China from 2008 to 2018 (in million U.S. dollars)." Chart. October 14, 2014. Statista. Accessed November 09, 2024. https://www.statista.com/forecasts/332392/china-biotechnology-randd-revenue-forecast-sic-7211
Statista. (2014). Revenue of biotechnology R&D (SIC 72.11) in China from 2008 to 2018 (in million U.S. dollars). Statista. Statista Inc.. Accessed: November 09, 2024. https://www.statista.com/forecasts/332392/china-biotechnology-randd-revenue-forecast-sic-7211
Statista. "Revenue of Biotechnology R&d (Sic 72.11) in China from 2008 to 2018 (in Million U.S. Dollars)." Statista, Statista Inc., 14 Oct 2014, https://www.statista.com/forecasts/332392/china-biotechnology-randd-revenue-forecast-sic-7211
Statista, Revenue of biotechnology R&D (SIC 72.11) in China from 2008 to 2018 (in million U.S. dollars) Statista, https://www.statista.com/forecasts/332392/china-biotechnology-randd-revenue-forecast-sic-7211 (last visited November 09, 2024)
Revenue of biotechnology R&D (SIC 72.11) in China from 2008 to 2018 (in million U.S. dollars) [Graph], Statista, October 14, 2014. [Online]. Available: https://www.statista.com/forecasts/332392/china-biotechnology-randd-revenue-forecast-sic-7211